How many email patterns does Samus Therapeutics, Inc. use?

Samus Therapeutics, Inc. uses 1 known email pattern.

What domain does Samus Therapeutics, Inc. use for work emails?

Samus Therapeutics, Inc. uses samustherapeutics.com for work email addresses.

Most Common Email Formats at Samus Therapeutics, Inc.

The most accurate and popular Samus Therapeutics, Inc.'s email format is LastF@samustherapeutics.com (ex. DoeJ@samustherapeutics.com). Samus Therapeutics, Inc. also uses as email structures. Samus Therapeutics, Inc. uses up to 1 different email patterns.

Samus Therapeutics, Inc. Email Formats	Example	Percentage
LastF@samustherapeutics.com	DoeJ@samustherapeutics.com	100%

Samus Therapeutics, Inc. Email Formats

Example

Percentage

LastF@samustherapeutics.com

DoeJ@samustherapeutics.com

100%

Frequently Asked Questions

What does Samus Therapeutics, Inc. do?

Samus Therapeutics, Inc. was founded in 2016 and operates in the Pharmaceuticals industry, alongside similar companies like Roche, sanofi and Johnson & Johnson. You can visit samustherapeutics.com. Explore Samus Therapeutics, Inc.'s company overview page for more information.

What is Samus Therapeutics, Inc.'s email address format?

Samus Therapeutics, Inc.'s email format typically follows the pattern of LastF@samustherapeutics.com; this email format is used 100% of the time. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Samus Therapeutics, Inc. have currently?

Samus Therapeutics, Inc. has approximately 11 employees as of July 2026. Key team members to contact include Chief Scientific Officer: B. W. For more team information and contact data, explore Samus Therapeutics, Inc.'s employee directory with LeadIQ.

Samus Therapeutics, Inc. Email Format

PharmaceuticalsMassachusetts, United States11-50 Employees

Samus Therapeutics, Inc. is a privately held biopharmaceutical company based in the Boston area, focused on developing therapeutics that target the epichaperome, a protein complex implicated in various diseases including cancer and neurodegenerative disorders. The company's lead oncology program aims to inhibit this complex, with clinical studies currently in early-phase stages for breast cancer and myelofibrosis, while its central nervous system program targets neurodegenerative epichaperome activity through a separate compound being investigated in Alzheimer’s disease along with biomarker efforts to map the epichaperome distribution in the brain. In parallel, Samus is advancing companion biomarker programs that support imaging and cellular analysis to accompany its therapeutic initiatives. Founded by researchers associated with prominent institutions and led by CEO Jonathan Lewis, the company operates from Massachusetts and maintains a research-focused portfolio that integrates oncology and neurology efforts.

Most Common Email Formats at Samus Therapeutics, Inc.

Frequently Asked Questions

What does Samus Therapeutics, Inc. do?

What is Samus Therapeutics, Inc.'s email address format?

How many employees does Samus Therapeutics, Inc. have currently?

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

Samus Therapeutics, Inc. Email Format

Verify Samus Therapeutics, Inc. email addresses

Ready to create more pipeline?

Ready to create more pipeline?

Most Common Email Formats at Samus Therapeutics, Inc.

Frequently Asked Questions

What does Samus Therapeutics, Inc. do?

What is Samus Therapeutics, Inc.'s email address format?

How many employees does Samus Therapeutics, Inc. have currently?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Samus Therapeutics, Inc. Email Format

Verify Samus Therapeutics, Inc. email addresses

Ready to create more pipeline?

Ready to create more pipeline?

Everything for prospecting,
in one platform.